Global Dydrogesterone Market by Type (Dydrogesterone D5, Dydrogesterone D6), Application (Gynecological Diseases, Infertility) - Forecast 2024-2030- Product Image

Sale

Global Dydrogesterone Market by Type (Dydrogesterone D5, Dydrogesterone D6), Application (Gynecological Diseases, Infertility) - Forecast 2024-2030

Report
199 Pages
March 2024
Region: Global
360iResearch™
ID: 5924829

UP TO €846EUR$875USD£725GBP OFF until Dec 31^st 2024

The Dydrogesterone Market size was estimated at USD 567.86 million in 2023, USD 618.12 million in 2024, and is expected to grow at a CAGR of 9.45% to reach USD 1,069.00 million by 2030.

Dydrogesterone is a synthetic hormone similar in chemical structure and pharmacological effect to endogenous progesterone. It is classified as a progestin, which is a type of medication used to replicate the effects of the natural hormone progesterone. Dydrogesterone possesses a strong progestational effect, which makes it highly suitable for conditions related to progesterone deficiency. It is frequently employed in a variety of clinical situations, such as menstrual disorders, infertility owing to luteal insufficiency, and as part of hormone replacement therapy (HRT) for menopausal symptoms. Unlike some other synthetic progestins, dydrogesterone does not inhibit ovulation at therapeutic doses, making it a preferred option in cases where maintenance of ovulatory cycles is desired. The dydrogesterone market is exhibiting growth with an increasing elderly female population and prevalence of reproductive health issues, improved healthcare infrastructure, medical advancements, and supportive government policies for women's health. Despite the growth prospects, challenges such as stringent drug approval regulations, side effects, and competitive alternatives for dydrogesterone hinder the scope of the market. However, developing novel drug delivery mechanisms, introducing generic versions for cost-effectiveness, and investigating combination therapies for broader therapeutic applications present lucrative opportunities for future market growth.

Regional Insights

The dydrogesterone market in the Americas is experiencing a steady growth pattern. The increase in awareness regarding women's health issues and the prevalence of conditions, including endometriosis and irregular menstrual cycles in the female population, bolster the demand for hormone-related treatment options. The United States is a significant contributor to market growth within this region owing to the well-established healthcare infrastructure, presence of major pharmaceutical companies, and supportive regulatory framework. This is coupled with a higher purchasing power and insurance coverage for such medications, aiding in the positive trajectory of the dydrogesterone market. Europe is a major contributor to the dydrogesterone market in the EMEA, with widespread acceptance of hormone replacement therapies and favorable healthcare reimbursement policies. The region's mature healthcare systems contribute to its strong market position. Meanwhile, the Middle East and Africa regions show potential for growth, albeit at a slower rate compared to Europe, due to increasing healthcare investments and the gradual spread of awareness regarding women's reproductive health. The market for dydrogesterone in the Asia-Pacific region is expected to experience the highest growth rate. Factors fueling this expansion include the rising incidence of gynecological disorders, an increase in the female working population, improving healthcare infrastructure, and growing awareness around women's health issues. Particularly, countries including China and India have burgeoning pharmaceutical sectors and represent considerable markets owing to their large populations and increasing medical tourism.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Dydrogesterone Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Dydrogesterone Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Dydrogesterone Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adalvo Limited, Alembic Pharmaceuticals Limited, Axios Research, Clearsynth, Dr. D Pharma, Gufic Group, H & Care Incorp, Jagsonpal Pharmaceuticals Ltd., Mankind Pharma Limited, Medley Pharmaceuticals Ltd., Merck KGaA, Sandoo Pharmaceuticals and Chemcials Co.,Ltd., Santa Cruz Biotechnology, Inc., Simson Pharma Limited, Solitaire Pharmacia Private Limited, Somacare, Synokem Pharmaceuticals Ltd., Taj Pharmaceuticals Limited, Theramex, TLC Pharmaceutical Standards Ltd., Viatris Inc., VIVAN Life Sciences, and Zuventus Healthcare Limited.

Market Segmentation & Coverage

This research report categorizes the Dydrogesterone Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Dydrogesterone D5
- Dydrogesterone D6
Application
- Gynecological Diseases
- Infertility

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Dydrogesterone Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Dydrogesterone Market?
What are the technology trends and regulatory frameworks in the Dydrogesterone Market?
What is the market share of the leading vendors in the Dydrogesterone Market?
Which modes and strategic moves are suitable for entering the Dydrogesterone Market?

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Dydrogesterone Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing elderly female population and prevalence of reproductive health issues
5.1.1.2. Supportive government policies for women's health
5.1.1.3. Improved healthcare infrastructure across economies
5.1.2. Restraints
5.1.2.1. High costs associated with dydrogesterone production
5.1.3. Opportunities
5.1.3.1. Rising approval of generic dydrogesterone drugs
5.1.3.2. Growing investment and expansion by market players
5.1.4. Challenges
5.1.4.1. Stringent regulatory approval processes associated with dydrogesterone drugs
5.2. Market Segmentation Analysis
5.2.1. Type: Benefits of dydrogesterone d6 in highly precise analytical and clinical tests
5.2.2. Application: Significant applications of dydrogesterone for symptomatic relief and hormonal regulation in gynecological conditions
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Dydrogesterone Market, by Type
6.1. Introduction
6.2. Dydrogesterone D5
6.3. Dydrogesterone D6

7. Dydrogesterone Market, by Application
7.1. Introduction
7.2. Gynecological Diseases
7.3. Infertility

8. Americas Dydrogesterone Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Dydrogesterone Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Dydrogesterone Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
11.3.1. Merger & Acquisition
11.3.1.1. Theramex Announces Agreement to Acquire the European Rights to Duphaston and Femoston From Viatris, Inc.
11.3.2. Award, Recognition, & Expansion
11.3.2.1. Aurisco Gets Auxiton (Dydrogesterone) as First Generic Approval in China
11.3.2.2. US Pharma Giant Applies for Nod to Launch Tweaked Version of Drug for Pelvic Pain in Endometriosis

12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Abbott Laboratories
12.1.2. Adalvo Limited
12.1.3. Alembic Pharmaceuticals Limited
12.1.4. Axios Research
12.1.5. Clearsynth
12.1.6. Dr. D Pharma
12.1.7. Gufic Group
12.1.8. H & Care Incorp
12.1.9. Jagsonpal Pharmaceuticals Ltd.
12.1.10. Mankind Pharma Limited
12.1.11. Medley Pharmaceuticals Ltd.
12.1.12. Merck KGaA
12.1.13. Sandoo Pharmaceuticals and Chemcials Co.,Ltd.
12.1.14. Santa Cruz Biotechnology, Inc.
12.1.15. Simson Pharma Limited
12.1.16. Solitaire Pharmacia Private Limited
12.1.17. Somacare
12.1.18. Synokem Pharmaceuticals Ltd.
12.1.19. Taj Pharmaceuticals Limited
12.1.20. Theramex
12.1.21. TLC Pharmaceutical Standards Ltd.
12.1.22. Viatris Inc.
12.1.23. VIVAN Life Sciences
12.1.24. Zuventus Healthcare Limited
12.2. Key Product Portfolio

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
FIGURE 1. DYDROGESTERONE MARKET RESEARCH PROCESS
FIGURE 2. DYDROGESTERONE MARKET SIZE, 2023 VS 2030
FIGURE 3. DYDROGESTERONE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. DYDROGESTERONE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. DYDROGESTERONE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DYDROGESTERONE MARKET DYNAMICS
FIGURE 7. DYDROGESTERONE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. DYDROGESTERONE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES DYDROGESTERONE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES DYDROGESTERONE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. DYDROGESTERONE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. DYDROGESTERONE MARKET SHARE, BY KEY PLAYER, 2023

List of Tables
TABLE 1. DYDROGESTERONE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. DYDROGESTERONE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DYDROGESTERONE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. DYDROGESTERONE MARKET SIZE, BY DYDROGESTERONE D5, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. DYDROGESTERONE MARKET SIZE, BY DYDROGESTERONE D6, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 9. DYDROGESTERONE MARKET SIZE, BY GYNECOLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. DYDROGESTERONE MARKET SIZE, BY INFERTILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. AMERICAS DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 12. AMERICAS DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 13. AMERICAS DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 14. ARGENTINA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 15. ARGENTINA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. BRAZIL DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 17. BRAZIL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. CANADA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 19. CANADA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. MEXICO DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 21. MEXICO DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES DYDROGESTERONE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 25. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 28. AUSTRALIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. AUSTRALIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. CHINA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. CHINA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. INDIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. INDIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. INDONESIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. INDONESIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. JAPAN DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. JAPAN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. MALAYSIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. MALAYSIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. PHILIPPINES DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. PHILIPPINES DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. SINGAPORE DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. SINGAPORE DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. SOUTH KOREA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. SOUTH KOREA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. TAIWAN DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. TAIWAN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. THAILAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. THAILAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. VIETNAM DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. VIETNAM DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. DENMARK DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. DENMARK DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. EGYPT DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. EGYPT DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. FINLAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. FINLAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. FRANCE DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. FRANCE DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. GERMANY DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. GERMANY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. ISRAEL DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. ISRAEL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. ITALY DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. ITALY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. NETHERLANDS DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. NETHERLANDS DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. NIGERIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. NIGERIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. NORWAY DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. NORWAY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. POLAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. POLAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. QATAR DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. QATAR DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. RUSSIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. SAUDI ARABIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. SAUDI ARABIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. SOUTH AFRICA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. SOUTH AFRICA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. SPAIN DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. SPAIN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. SWEDEN DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. SWEDEN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. SWITZERLAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. SWITZERLAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. TURKEY DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. TURKEY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. UNITED ARAB EMIRATES DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. DYDROGESTERONE MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 98. DYDROGESTERONE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 99. DYDROGESTERONE MARKET LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
Adalvo Limited
Alembic Pharmaceuticals Limited
Axios Research
Clearsynth
Dr. D Pharma
Gufic Group
H & Care Incorp
Jagsonpal Pharmaceuticals Ltd.
Mankind Pharma Limited
Medley Pharmaceuticals Ltd.
Merck KGaA
Sandoo Pharmaceuticals and Chemcials Co.,Ltd.
Santa Cruz Biotechnology, Inc.
Simson Pharma Limited
Solitaire Pharmacia Private Limited
Somacare
Synokem Pharmaceuticals Ltd.
Taj Pharmaceuticals Limited
Theramex
TLC Pharmaceutical Standards Ltd.
Viatris Inc.
VIVAN Life Sciences
Zuventus Healthcare Limited

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	199
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 618.12 Million
Forecasted Market Value ( USD ) by 2030	$ 1069 Million
Compound Annual Growth Rate	9.4%
Regions Covered	Global
No. of Companies Mentioned	24

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3263EUR$3,374USD£2,796GBP €3625EUR$3,749USD£3,107GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4133EUR$4,274USD£3,542GBP €4593EUR$4,749USD£3,936GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5004EUR$5,174USD£4,288GBP €5560EUR$5,749USD£4,765GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5874EUR$6,074USD£5,034GBP €6527EUR$6,749USD£5,594GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7615EUR$7,874USD£6,526GBP €8461EUR$8,749USD£7,251GBP

Regional Insights

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Dydrogesterone (CAS 152-62-5) Global Market Research Report 2024

Dydrogesterone: 2017 Global and Regional Analysis and Forecast to 2022

Global Progestrone Market by Type (Natural Progesterone, Synthetic Progesterone), Mode of Delivery (Injectable, Oral, Suspended Form), Application - Forecast 2023-2030

Global Male Infertility Market by Test (Computer-Assisted Semen Analysis, DNA Fragmentation Technique, Microscopic Examination), Treatment (Assisted Reproductive Technology, Medication) - Forecast 2024-2030

Global Herpes Simplex Virus Treatment Market Size, Share & Trends Analysis Report by Type (HSV-1, HSV-2), Drug (Acyclovir, Valacyclovir, Famciclovir), Vaccine (Simplirix, Others), Route of Administration, End-use, Region, and Segment Forecasts, 2024-2030

About the Dydrogesterone Market